Meanwhile, the NAFLD characteristic genes identified in this study, especially MAFB and CX3CR1, may shed new light on the clinical development of effective diagnosis and treatment of NAFLD. Here, CX3CR1 is linked to metabolic dysfunction-associated steatotic liver disease.